Abirami Shankar
Overview
Explore the profile of Abirami Shankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakthavatchalam Y, Manoharan Y, Shankar A, Gunasekaran K, Walia K, Veeraraghavan B
Eur J Clin Microbiol Infect Dis
. 2024 Sep;
43(12):2453-2457.
PMID: 39297907
Stenotrophomonas maltophilia is challenging to treat due to the presence of multiple intrinsic and acquired resistance mechanisms. TMP-SMZ is the standard care of therapy for treating S. maltophilia infections; levofloxavin...
2.
Bakthavatchalam Y, Shankar A, Manokaran Y, Walia K, Veeraraghavan B
JAC Antimicrob Resist
. 2023 Mar;
5(2):dlad016.
PMID: 36880086
NDM-expressing infections are challenging to treat, due to limited treatment options. with four-amino acid inserts (YRIN/YRIK) are also common in India and it has been reported to reduce the susceptibility...
3.
Bakthavatchalam Y, Elangovan D, Jaganathan S, Subburaju N, Shankar A, Manokaran Y, et al.
Microbiol Spectr
. 2023 Feb;
:e0492522.
PMID: 36847537
In recent times, discovery efforts for novel antibiotics have mostly targeted carbapenemase-producing Gram-negative organisms. Two different combination approaches are pertinent: β-lactam-β-lactamase inhibitor (BL/BLI) or β-lactam-β-lactam enhancer (BL/BLE). Cefepime combined with...
4.
Bakthavatchalam Y, Basu S, Shankar A, Ramaiah S, Anbarasu A, Veeraraghavan B
Diagn Microbiol Infect Dis
. 2022 Dec;
105(3):115878.
PMID: 36529021
The present study reported a rare gentamicin-susceptible β-lactamase (PenA, OXA-57) expressing clinical Burkholderia pseudomallei isolate VB29710 from India. Whole-genome sequencing and structural analyses revealed the insertion of R962 and L963...
5.
Bakthavatchalam Y, Shankar A, Muniyasamy R, Peter J, Marcus Z, Dwarakanathan H, et al.
J Antimicrob Chemother
. 2020 May;
75(8):2156-2159.
PMID: 32361727
Objectives: Levonadifloxacin (WCK 771; IV) and its prodrug alalevonadifloxacin (WCK 2349; oral) are benzoquinolizine fluoroquinolones, recently approved in India for the treatment of acute bacterial skin and skin structure infections...
6.
Bakthavatchalam Y, Shankar A, Muthuirulandi Sethuvel D, Asokan K, Kanthan K, Veeraraghavan B
Future Sci OA
. 2020 Apr;
6(4):FSO461.
PMID: 32257374
Aim: To evaluate the antibacterial activity of fosfomycin-meropenem and fosfomycin-colistin combinations against carbapenem-resistant (CR-Kp). Methods: A total of 50 CR-Kp isolates recovered from blood cultures were included in this study....
7.
Bakthavatchalam Y, Shankar A, Thukaram B, Krishnan D, Veeraraghavan B
J Infect Dev Ctries
. 2020 Jan;
12(6):504-507.
PMID: 31940304
No abstract available.